Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ohio State University Comprehensive Cancer Center
With
National Cancer Institute (NCI)
PRIMARY OBJECTIVE:
I. Test the feasibility of the PN intervention and of recruiting participants to a randomized controlled trial of the intervention.
OUTLINE: Participants are randomized to 1 of 2 arms.
ARM I: Participants receive links to informational websites on breast cancer risk and risk management options on study. Participants also receive phone calls from a single patient navigator and discuss breast cancer risk and risk-management options once a month for 8 months. Participants may choose to receive additional patient navigator phone calls as needed on study.
ARM II: Participants receive links to informational websites on breast cancer risk and risk management options on study.
After completion of study intervention, participants are followed for up to 1 month.
Age
18–75
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Are non-Hispanic Black or non-Hispanic white
Identify as women
Are between 18 and 75 years old
Have been identified as at potentially high risk by a population-based risk screening program
Have never been diagnosed with breast or ovarian cancer
Are early in their risk-management adoption process, defined as currently identifying with stage 0 (never heard of it) or 1 (haven't decided) of the risk-management adoption pathway (R-MAP) in relation to at least one of the four risk-management actions recommended for all high-risk women: attending genetic counseling appointment, having a personalized risk assessment, undergoing annual clinical breast exams, and considering chemoprevention
Who do not believe cancer can be prevented and/or have not received risk-management guidance from a specialist
